5 ASX stocks that Australian Ethical bought or sold recently
We often like to look at shares that well known ASX fund managers are trading, and today we’re looking at…
Should you invest in aged care stocks? Here are 4 reasons to consider them, and 4 reasons to avoid them
Should you invest in aged care stocks? There are plenty of things to like about this sector, including government funding,…
IGO shares shed 66% in 14 months – will they bounce back or are you catching a falling knife?
For several years IGO shares reaped the benefits of growing demand for battery metals and the fact it was well…
Intelligent Monitoring Group (ASX:IMB): It is Australasia’s largest independent security monitoring provider and is up >200% in 12 months!
Intelligent Monitoring Group (ASX:IMB) has had a terrific FY24. It made >$40m EBITDA, went from being the 3rd largest company…
Here’s what you need to know about the TGA Special Access Scheme and why its a game changer for ASX biotechs
For ASX biotechs wishing to commercialise drugs in Australia, the Therapeutic Goods Administration (TGA) Special Access Scheme is the next best…
How will the stock market do tomorrow? Here’s how Stock Futures can be a reliable indicator to that question
How will the stock market do tomorrow? All investors wonder this question, yet the only way they know for sure…
After a 60% plunge in 4 months, are Mineral Resources (ASX:MIN) and its lithium peers on the rebound?
Mineral Resources (ASX:MIN) avoided much of the lithium price rout, until a few months ago. For investors, the company’s diversification…
Chinese Mine Shutdown: Is This the Perfect Time to Invest in ASX Lithium Stocks?
The closure of a significant lithium mine run by CATL in China has sent shockwaves through the global lithium market.…
The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!
The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and…
Gearing: What is it and how can companies exploit it to their advantage?
You may hear a company talk about its gearing. Generally only when it has a low level of gearing, of…
Immutep (ASX:IMM): Set to commercialise its lung cancer treatment by 2027
Developing a cancer drug is a long journey, but Immutep (ASX:IMM) is more towards the end than the start. A…
After Nvidia’s Rally: Is It Time to Invest in Asian Chip Stocks?
Nvidia, a top-tier company in the world of graphics processing units (GPUs), has recently enjoyed a meteoric rise in its…
Private equity: Here’s what it is, and how the sector can be a blessing and a curse to retail investors
You may have heard of the term ‘Private Equity’ (PE) before. You may have seen a company been taken over…
Adobe (NDQ:ADBE): The 42-year old company behind PhotoShop and PDFs may have an even richer future ahead, driven by AI
Outside the so-called Magnificant Seven stocks, Adobe (NDQ:ADBE) is one of the most well-known by investors, as well as the…
Here are 6 stocks that got promoted in the ASX quarterly rebalance, and 6 that got demoted
On Monday September 23, the ASX quarterly rebalance will be effective. Stocks will be promoted into new indices, while others…